Study of the drug release mechanism from tyrphostin AG-1295-loaded nanospheres by in situ and external sink methods

Journal of Controlled Release

Volumn 83, Issue 3, 2002, Pages 401-414

  Chorny, Michael ^a   Fishbein, Ilia ^a   Danenberg, Haim D ^b   Golomb, Gershon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Controlled release; Diffusion; Drug release; Nanoparticles; Nanoprecipitation; Nanospheres; Tyrphostin

Indexed keywords

6,7 DIMETHYL 2 PHENYLQUINOXALINE; NANOPARTICLE; POLYMER; TYRPHOSTIN;

ADSORPTION; ARTICLE; DISSOCIATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG TRANSPORT; ENCAPSULATION; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR WEIGHT; PRECIPITATION; PRIORITY JOURNAL; RESTENOSIS;

CHEMISTRY, PHARMACEUTICAL; MICROSPHERES; NANOTECHNOLOGY; TECHNOLOGY, PHARMACEUTICAL; TYRPHOSTINS;

EID: 0037202149     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00210-9     Document Type: Article

References (33)

1. Banai S., Wolf Y., Golomb G., Pearle A., Waltenberger J., Fishbein I., Schneider A., Gazit A., Perez L., Huber R., Lazarovichi G., Rabinovich L., Levitzki A., Gertz S.D. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation. 97:1998;1960-1969.
2. Fishbein I., Waltenberger J., Banai S., Rabinovich L., Chorny M., Levitzki A., Gazit A., Huber R., Mayr U., Gertz S.D., Golomb G. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arterioscler Thromb Vasc Biol. 20:2000;667-676.
3. M. Chorny, I. Fishbein, H.D. Danenberg, G. Golomb, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics, J. Control. Release (2002) this issue.
4. Fishbein I., Chorny M., Banai S., Levitzki A., Danenberg H.D., Gao J., Chen X., Moerman E., Gati I., Goldwasser V., Golomb G. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol. 21:2001;1434-1439.
5. Pecora R. Dynamic light scattering measurement of nanometer particles in liquids. J. Nanoparticle Res. 2:2000;123-131.
6. J.W. Kostanski, P.P. DeLuca, A novel in vitro release technique for peptide-containing biodegradable microspheres (article 4) AAPS PharmSciTech 1 (1) (2000) (http:/www.pharmscitech.com).
7. ® from poly(D,L-lactic acid) nanoparticles coated with albumin or polyvinyl alcohol in model digestive fluids (USP XXII). J. Control. Release. 44:1997;227-236.
8. Levy M.Y., Benita S. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. Int. J. Pharm. 66:1990;29-37.
9. Magenheim B., Levy M.Y., Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int. J. Pharm. 94:1993;115-123.
10. Washington C. Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition. Int. J. Pharm. 56:1989;71-74.
11. Washington C., Koosha F. Drug release from microparticulates; deconvolution of measurement errors. Int. J. Pharm. 59:1990;79-82.
12. Washington C. Drug release from microdisperse systems: a critical review. Int. J. Pharm. 58:1990;1-12.
13. Illum L., Khan M.A., Mak E., Davis S.S. Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int. J. Pharm. 30:1986;17-28.
14. Lin W., Garnett M.C., Davis S.S., Schacht E., Ferruti P., Illum L. Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles. J. Control. Release. 71:2001;117-126.
15. Redhead H.M., Davis S.S., Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release. 70:2001;353-363.
16. Weber G., Farris F.J. Synthesis and spectral properties of a hydrophobic fluorescent probe: 6-propionyl-2-(dimethylamino)naphthalene. Biochemistry. 18:1979;3075-3078.
17. Fishbein I., Chorny M., Rabinovich L., Banai S., Gati I., Golomb G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. J. Control. Release. 65:2000;221-229.
18. Guy R.H., Hadgraft J., Kellaway I.W., Taylor M.J. Calculations of drug release rates from spherical particles. Int. J. Pharm. 11:1982;199-207.
19. Baker R.W., Lonsdale H.K. Controlled release: mechanisms and rates. Tanquary A.C., Lacey R.E., Controlled Release of Biologically Active Agents. Vol. 47:1974;15-71 Plenum, New York.
20. Ritger P.L., Peppas N.A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release. 5:1987;37-42.
21. Ritger P.L., Peppas N.A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the forms of slabs, spheres, cylinders or discs. J. Control. Release. 5:1987;23-36.
22. Sinclair G.W., Peppas N.A. Analysis of non-Fickian transport in polymers using simplified exponential expressions. J. Membrane Sci. 17:1984;329-331.
23. Washington C. Drug release from microparticulate systems. Benita S., Microencapsulation. Methods and Industrial Applications. Vol. 73:1996;155-181 Marcel Dekker, New York.
24. Magalhaes N.S., Fessi H., Puisieux F., Benita S., Seiller M. An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride. J. Microencap. 12:1995;195-205.
25. Golomb G., Fishbein I. Tyrphostins, inhibitors of protein tyrosine kinase, in restenosis. Adv. Drug Deliv. Rev. 24:1997;53-62.
26. Belbella A., Vauthier C., Fessi H., Devissaguet J.P., Puisieux F. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. Int. J. Pharm. 129:1996;95-102.
27. Lemoine D., Francois C., Kedzierewicz F., Preat V., Hoffman M., Maincent P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials. 17:1996;2191-2197.
28. Peppas N.A. Release of bioactive agents from swellable polymers: theory and experiments. Anderson J.M., Kim S.W., Recent Advances in Drug Delivery Systems. 1984;279-289 Plenum, New York.
29. Polakovic M., Görner T., Gref R., Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J. Control. Release. 60:1999;169-177.
30. Liggins R.T., Burt H.M. Paclitaxel loaded poly(L-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. Int. J. Pharm. 222:2001;19-33.
31. Görner T., Gref R., Michenot D., Sommer F., Tran M.N., Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J. Control. Release. 57:1999;259-268.
32. Wehrle P., Magenheim B., Benita S. The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design. Eur. J. Pharm. Biopharm. 41:1995;19-26.
33. Li W.-I., Anderson K.W., DeLuca P.P. Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. J. Control. Release. 37:1995;187-198.